IPP Bureau
USFDA approves Pfizer’s Velsipity for adults with Ulcerative Colitis
By IPP Bureau - October 20, 2023
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
Bajaj Healthcare completes construction of Alkaloid extraction plant at Vadodara
By IPP Bureau - October 19, 2023
The plant has a capacity for extraction of 2500 mt of poppy straw and 300 mt poppy gum per year
75% of newly emerging infectious diseases over last three decades are zoonotic in nature: Union Health Secretary
By IPP Bureau - October 19, 2023
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
.jpg "GenWorks Health & Rotary Club partners to transform rural healthcare")
GenWorks Health & Rotary Club partners to transform rural healthcare
By IPP Bureau - October 19, 2023
GenWorks Health Introduces Braster Pro for breast screening & EVA for cervical screening in rural areas & communities
Clariant launches new range of excipients to improve stability and solubility of APIs at CPHI Barcelona
By IPP Bureau - October 19, 2023
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
Evonik launches Eudracap preclinic functional oral capsule for preclinical trials
By IPP Bureau - October 19, 2023
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Syngene Q2 FY23-24 revenue from operations up 18.5% to Rs 910 Cr
By IPP Bureau - October 18, 2023
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Glenmark to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 diabetes
By IPP Bureau - October 18, 2023
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
USFDA inspection at Biocon Biologics' manufacturing facility in Johor, Malaysia
By IPP Bureau - October 18, 2023
Shilpa Medicare Unit IV, Jadcherla has cleared TGA, Australia GMP inspection
By IPP Bureau - October 18, 2023
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Glenmark receives ANDA approval for Apremilast Tablets
By IPP Bureau - October 18, 2023
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site
By IPP Bureau - October 17, 2023
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Lupin enters into BTA with Lupin Manufacturing Solutions
By IPP Bureau - October 17, 2023
Lupin enters into BTA with Lupin Manufacturing Solutions
Satish Pandurang Samant appointed CEO of Vineet Laboratories
By IPP Bureau - October 16, 2023
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Mankind Pharma appoints Prateek Dubey as President - Global CHRO
By IPP Bureau - October 16, 2023
Prateek has more than 23 years of rich experience in Human Resource
